Fingerprint
Dive into the research topics of 'LAG3 (CD223) as a cancer immunotherapy target'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews, Ariel E. Marciscano, Charles G. Drake, Dario A A Vignali
Research output: Contribution to journal › Review article › peer-review
254
Scopus
citations